Novel Substituted Benzothiazole Compounds for Treating Huntington's Disease
- PMID: 33859791
- PMCID: PMC8040037
- DOI: 10.1021/acsmedchemlett.1c00148
Novel Substituted Benzothiazole Compounds for Treating Huntington's Disease
Conflict of interest statement
The author declares no competing financial interest.
Similar articles
-
Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease.ACS Med Chem Lett. 2021 Nov 15;12(12):1881-1882. doi: 10.1021/acsmedchemlett.1c00607. eCollection 2021 Dec 9. ACS Med Chem Lett. 2021. PMID: 34917244 Free PMC article. No abstract available.
-
Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease.ACS Med Chem Lett. 2021 Jul 20;12(8):1204-1205. doi: 10.1021/acsmedchemlett.1c00356. eCollection 2021 Aug 12. ACS Med Chem Lett. 2021. PMID: 34413943 Free PMC article. No abstract available.
-
Novel Substituted Monocyclic Heteroaryl Compounds for Treating Huntington's Disease.ACS Med Chem Lett. 2020 Dec 10;12(1):5-6. doi: 10.1021/acsmedchemlett.0c00622. eCollection 2021 Jan 14. ACS Med Chem Lett. 2020. PMID: 33488955 Free PMC article. No abstract available.
-
Investigational agents for the management of Huntington's disease.Expert Opin Investig Drugs. 2017 Feb;26(2):175-185. doi: 10.1080/13543784.2017.1270266. Epub 2016 Dec 16. Expert Opin Investig Drugs. 2017. PMID: 27927041 Review.
-
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?Curr Opin Neurol. 2003 Aug;16(4):465-70. doi: 10.1097/01.wco.0000084223.82329.bb. Curr Opin Neurol. 2003. PMID: 12869804 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources